載入...

Diffuse pulmonary lymphangiomatosis treated with bevacizumab

Diffuse pulmonary lymphangiomatosis (DPL) is a rare disease caused by uncontrolled lymphatic vessel proliferation resulting in respiratory dysfunction. Lymphatic vessel growth is influenced by vascular endothelial growth factor (VEGF). It has been shown that bevacizumab, a monoclonal antibody to VEG...

全面介紹

Na minha lista:
書目詳細資料
發表在:Respirol Case Rep
Main Authors: Onyeforo, Ernest, Barnett, Adrian, Zagami, Debbie, Deller, David, Feather, Iain
格式: Artigo
語言:Inglês
出版: John Wiley & Sons, Ltd 2018
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6260917/
https://ncbi.nlm.nih.gov/pubmed/30510764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.384
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!